Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Iovance Biotherapeutics, Inc. (IOVA) had Return on Tangible Equity of -86.96% for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$164.07M
Net Income	$-372.18M
Cost of Goods Sold	$124.00M
Gross Profit	$40.08M
Operating Expenses	$559.35M
Operating Income	$-395.28M
Non-Operating Income/Expense	$20.27M
Pre-Tax Income	$-375.00M
Normalized Pre-Tax Income	$-375.00M
Income after Taxes	$-372.18M
Income from Continuous Operations	$-372.18M
Consolidated Net Income/Loss	$-372.18M
Normalized Income after Taxes	$-372.18M
EBIT	$-395.28M
EBITDA	$-361.93M
Weighted-Average Shares Outstanding (Basic)	289.88M
Weighted-Average Shares Outstanding (Diluted)	289.88M
Earnings per Share (EPS) (Basic)	$-1.28
Earnings per Share (EPS) (Diluted)	$-1.28
Balance Sheet Financials
Current Assets	$457.02M
Property, Plant, and Equipment	$109.08M
Long-Term Assets	$453.41M
Total Assets	$910.43M
Current Liabilities	$122.34M
Long-Term Debt	$1.00M
Long-Term Liabilities	$77.68M
Total Liabilities	$200.02M
Common Equity	$710.40M
Tangible Shareholders Equity	$428.01M
Shareholders Equity	$710.40M
Common Shares Outstanding	305.25M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-352.98M
Cash Flow from Investing Activities	$-96.41M
Cash Flow from Financial Activities	$390.66M
Beginning Cash	$181.32M
End Cash	$122.05M
Increase/Decrease in Cash	$-59.27M
Stock-Based Compensation	$109.63M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.74
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.00
Debt to Equity Ratio	0.00
Gross Margin	24.43%
Operating Margin	-240.92%
EBIT Margin	-240.92%
EBITDA Margin	-220.60%
Pre-Tax Profit Margin	-228.56%
Profit Margin	-226.84%
Free Cash Flow	$-364.05M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.18
Inventory Turnover	2.41
Receiveable Turnover	2.37
Days Sales in Receivables	154.26
Return on Equity	-52.39%
Return on Tangible Equity	-86.96%
Return on Assets	-40.88%
Return on Investments	-52.32%
Book Value Per Share	$2.33
Free Cash Flow per Share	$-1.26
Operating Cash Flow per Share	$-1.22

Data from Zacks Investment Research, Inc.